AI Analysis AI Analysis of IFRX AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add IFRX to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Big movements in InflaRx N.V. stock price on Tuesday moving 11.39% between high and low
(Updated on Jun 09, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jun 03, 2026 Loss -19.42%

The InflaRx N.V. stock price fell by -2.92% on the last day (Tuesday, 9th Jun 2026) from $1.71 to $1.66. It has now fallen 7 days in a row. During the last trading day the stock fluctuated 11.39% from a day low at $1.58 to a day high of $1.76. The price has fallen in 9 of the last 10 days and is down by -39.42% for this period. Volume has increased on the last day by 962 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $3.54 million.

Given the current short-term trend, the stock is expected to rise 166.18% during the next 3 months and, with a 90% probability hold a price between $4.42 and $8.10 at the end of this 3-month period.

IFRX Signals & Forecast

There are few to no technical positive signals at the moment. The InflaRx N.V. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.96 and $2.17. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, May 26, 2026, and so far it has fallen -39.42%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for InflaRx N.V. stock

InflaRx N.V. finds support from accumulated volume at $1.59 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.180 between high and low, or 11.39%. For the last week, the stock has had daily average volatility of 9.49%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (IFRX) For The Upcoming Trading Day Of Wednesday 10th

For the upcoming trading day on Wednesday, 10th we expect InflaRx N.V. to open at $1.67, and during the day (based on 14 day Average True Range), to move between $1.55 and $1.77, which gives a possible trading interval of +/-$0.211 (+/-13.60%) up or down from last closing price. If InflaRx N.V. takes out the full calculated possible swing range there will be an estimated 13.60% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.67 (0.60%) than the support at $1.59 (4.22%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is InflaRx N.V. stock A Buy?

The InflaRx N.V. stock holds several negative signals and despite the positive trend, we believe InflaRx N.V. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.781 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 10, 2026 - $1.67 ( 0.402%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

IFRX Performance

Trading levels for IFRX

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 1.85 11.24%
R2 1.78 7.10%
R1 1.74 4.54%
Price 1.66
S1 1.60 -3.74%
S2 1.56 -6.30%
S3 1.49 -10.44%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.07 24.70%
R2 1.98 19.28%
R1 1.67 0.602%
Price 1.66
S1 1.59 -4.22%
S2 1.56 -6.02%
S3 1.48 -10.84%

FAQ

What is the symbol for InflaRx N.V. Stock and on which exchange is it traded?
The symbol for InflaRx N.V. is IFRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell InflaRx N.V. Stock?
The InflaRx N.V. stock holds several negative signals and despite the positive trend, we believe InflaRx N.V. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy InflaRx N.V. Stock?
InflaRx N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy InflaRx N.V. Stock.

What's the current price of InflaRx N.V. Stock?
As of the end of day on the Jun 09, 2026, the price of an InflaRx N.V. (IFRX) share was $1.66.

What is the 52-week high and low for InflaRx N.V. Stock?
The 52-week high for InflaRx N.V. Stock is $2.94 and the 52-week low is $0.741.

What is the market capitalization of InflaRx N.V. Stock?
As of the Jun 09, 2026, the market capitalization of InflaRx N.V. is 119.908M.

When is the next earnings date for InflaRx N.V.?
The upcoming earnings date for InflaRx N.V. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT INFLARX N.V.
InflaRx N.V
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c...
GOLDEN STAR
Ticker Change Signal Date
EAT
$140.46
7.38% Jun 05
TPR
$140.47
3.67% Jun 04
N
NVRI
$19.53
8.19% May 20
SAP
$172.39
3.79% May 05
GLBE
$31.61
2.44% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE